Thursday, April 3, 2025
spot_img

Ipsos: Monthly declaration of shares and voting rights – February 2025

March 28, 2025

MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS

Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMF

Date

 

Shares

 

Voting rights
Theoretical* Exercisable**
29 February 2025 43,203,225 48,748,321 48,510,585

*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights.

**For information purposes, this number excludes the shares which voting rights have been suspended.

The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en.

Attachment

  • Ipsos_Monthly declaration of voting rights_February 2025

Powered by SlickText.com

Hot this week

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

Topics

Transaction in Own Shares

         ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES ...

Adoption of the decisions of AS PRFoods noteholders by written procedure

AS PRFoods (registry code 11560713, registered address at Pärnu...

Notice on Calling the Annual General Meeting of Shareholders of as Tallinna Sadam

Dear shareholder! The management board of AS Tallinna...

DNO Releases 2024 Annual Report and Accounts

Oslo, 3 April 2025 – DNO ASA, the Norwegian...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Leiden, the Netherlands, April 3, 2025: Pharming Group N.V. (“Pharming”...

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT

SIKA EXPANDS PRESENCE IN ECUADOR WITH A NEW PLANT...

dsm-firmenich completes shareholding increase in Andre Pectin to 90.5%

Press Release dsm-firmenich completes shareholding increase in Andre...
spot_img

Related Articles

Popular Categories

spot_img